The effects on ovarian activity of ulipristal acetate when 'quickstarting' a combined oral contraceptive pill: A prospective, randomized, double-blind parallel-arm, placebo-controlled study

Human Reproduction

Volumn 30, Issue 7, 2015, Pages 1566-1572

  Cameron, S T ^a,b   Berger, C ^c   Michie, L ^a   Klipping, C ^d   Gemzell Danielsson, K ^c  

^a Chalmers Sexual Health Centre   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Dinox BV   (Netherlands)

Author keywords

combined oral contraceptive; emergency contraceptive; progesterone receptor modulator; quickstart; ulipristal acetate

Indexed keywords

ESTRADIOL; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PLACEBO; ULIPRISTAL; PREGNANE DERIVATIVE; PROGESTERONE RECEPTOR;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD; CONTRACEPTION; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; EMERGENCY CONTRACEPTION; FEMALE; FOLLICULAR PHASE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MEASUREMENT; MULTICENTER STUDY; NAUSEA; NETHERLANDS; OVARY FOLLICLE; OVARY FUNCTION; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RISK; SCORING SYSTEM; SWEDEN; TRANSVAGINAL ECHOGRAPHY; UNITED KINGDOM; CLINICAL TRIAL; DRUG EFFECTS; MENSTRUAL CYCLE; OVARY; OVULATION; PROCEDURES; YOUNG ADULT;

ADULT; CONTRACEPTION; CONTRACEPTION, POSTCOITAL; CONTRACEPTIVES, ORAL, COMBINED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MENSTRUAL CYCLE; NORPREGNADIENES; OVARY; OVULATION; PROSPECTIVE STUDIES; RECEPTORS, PROGESTERONE; YOUNG ADULT;

EID: 84936818636     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dev115     Document Type: Article

References (22)

1. Baerwald AR, Pierson RA. Ovarian follicular development during use of oral contraception: a review. J Obstet Gynecol Can 2004;26:19-24.
2. Baerwald AR, Olatunbosun OA, Pierson RA. Effects of oral contraceptives administered at defined stages of ovarian follicular development. Fertil Ster 2006;86:27-35.
3. Brache V, Cochon L, Deniaud M, Croxatto HB. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception 2013;88:611-618.
4. Cameron ST, Critchley HO, Buckley CH, Chard T, Kelly RW, Baird DT. The effects of post-ovulatory administration of onapristone on the developmnent of a secretory endometrium. Hum Reprod 1996; 11:40-49.
5. Cameron ST, Glasier A, JohnstoneA, Rae L. Ongoing contraception after use of emergency contraception from a specialist contraceptive service. Contraception 2011;84:368-371.
6. Centres for disease control and prevention. US selective practice recommendations for contraceptive use. 2013. www. cdc. gov/mmwr/ preview/mmwrhtml/rr6205a1. htm(8November2013, date last accessed).
7. Chen L, Zhu H, Wang A, Ren F, Chen J, Glasier A. Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel. Hum Reprod 2000;15:1969-1972.
8. Cheng L, Che Y, Gülmezoglu AM. Interventions for emergency contraception. Cochrane Database of Systematic Reviews 2012; Issue 8. Art. No. CD001324. DOI:10. 1002/14651858. CD001324. pub4.
9. Endrikat J, Gerlinger C, Plettig K, Wessel J, Schmidt W, Grubb G, Düsterberg B. A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use. Gynecol Endocrinol 2003;17:107-114.
10. Faculty of sexual and reproductive Healthcare. Quick start Guidance. 2010 www. fsrh. org. uk. (7 January 2014, date last accessed).
11. Gemzell-Danielsson K, Van Heusen AM, Killick SR, Croxatto HB, Bouchard P, Cameron ST, Bygdeman M. Improving cycle control in progestagen-only contraceptive pill users by intermittent treatment with a new antiprogestogen. Hum Reprod 2002;17:2588-2593.
12. Gemzell-Danielsson K, Berger C, P G L L. Emergency contraception mechanisms of action. Contraception 2013;87:300-308.
13. Glasier AF, Cameron ST, Fine PM, Logan SJ, CasaleW, Van Horn J, Sogor L, Blithe DL, Scherrer B, Mathe H et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized noninferiority trial and meta-analysis. Lancet 2010;375:555-562.
14. Hoogland HJ, Skouby SO. Ultrasound evaluation ofovarian activity under oral contraceptives. Contraception 1993;47:583-590.
15. Michie L, Cameron ST, GlasierA, LarkeN, Muir A, LorimerA. Pharmacy based interventions for initiating effective contraception following the use of emergency contraception: a pilot study. Contraception 2014;90:447-453.
16. Rible RD, Taylor D, Wilson ML, Stanczyk FZ, Mishell DR Jr. Follicular development in a 7-day versus 4-day hormone-free interval with an oral contraceptive containing 20 mcg ethinyl estradiol and 1 mg norethindrone acetate. Contraception 2009;79:182-188.
17. Smith SK, Kirkman RJE, Arce BB, McNeilly AS, Loudon NB, Baird DT. The effect of deliberate omission of trinordiol or microgynon on the hypothalamo-pituitary-ovarian axis. Contraception 1986;34:513-522.
18. Van Heusden AM, Killick SR, Coelingh Bennink HJT, Fauser BCJM. Single monthly administration of the anti-progestagen Org 31710 in users of the 75 mg desogestrel progestagen-only pill: effects on pituitary-ovarian activity. Hum Reprod 2000;15:629-636.
19. Weisberg E, Croxatto HB, Findlay JK, Burger HG, Fraser IS. A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanonw. Contraception 2011;84:600-608.
20. Westhoff CL, Torgal AH, Mayeda ER, Stanczyk FZ, Lerner JP, Benn EK, Paik M. Ovarian suppression in normal-weight and obese women during oral contraceptive use: a randomized controlled trial. Obstet Gynecol 2010;116:275-283.
21. WHO Medical eligibility criteria for contraceptive use 2009. http://www. who. int/reproductivehealth/publications/family-planning/9789241563 888/en/ (11 May 2015, date last accessed).
22. Wilcox AJ, Weinberg CR, Baird DD. Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby. N Engl J Med 1995;333:1517-1521.